Sign in

MR-Linac Consortium

@mrlconsortium.bsky.social
59 followers 11 following 53 posts
PostsRepliesMedia
MR-Linac Consortium @mrlconsortium.bsky.social · 09/03/2026
New results from the UNITED trial: smallmargin, weekly adaptive MRlinac treatment for glioblastoma significantly cuts normal brain dose (V60Gy ↓ from 146 - 157 → 84 - 93 cm³) and lowers brainstem/optic chiasm dose while maintaining target coverage. www.sciencedirect.com/science/arti...
sciencedirect.com
Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac: UNITED trial Organs-at-Risk Sparing
To assess the dosimetric impact to organs-at-risk (OARs) and target coverage of a small margin weekly adaptive treatment for glioblastoma delivered on…
000
MR-Linac Consortium @mrlconsortium.bsky.social · 02/03/2026
Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! Georgios Tsekas from the NKI, presents Direct-to-treatment MRI-guided prostate RT using a generic patient-agnostic reference plan. Register on the MR-Linac Consortium Member Portal. #ProgressThroughCollaboration
000
MR-Linac Consortium @mrlconsortium.bsky.social · 27/02/2026
There is still time to enter the MRgRT Spotlight competition! Don't miss out! members.mrlconsortium.org/event/mr-lin... #ProgressThroughCollaboration
000
MR-Linac Consortium @mrlconsortium.bsky.social · 16/02/2026
Behind the MR‑Linac Consortium's progress is a group dedicated to advancing what’s possible in cancer care. The Clinical Steering Committee drives research focus, quality excellence, and global collaboration—fueling the rapid expansion of MR‑guided radiotherapy and improving outcomes for patients.
000
MR-Linac Consortium @mrlconsortium.bsky.social · 10/02/2026
Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.
000
MR-Linac Consortium @mrlconsortium.bsky.social · 02/02/2026
Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.
000
MR-Linac Consortium @mrlconsortium.bsky.social · 27/01/2026
Abstract submissions for the MR‑Linac Consortium Meeting 2026 are now open! We welcome your research and insights as we prepare for an exciting gathering in Montreal. Submit your abstract today via the link in your emails or on the member portal. lnkd.in/ef3TrgGS #ProgressThroughCollaboration
000
MR-Linac Consortium @mrlconsortium.bsky.social · 05/01/2026
Ready to spotlight your expertise in MR-guided Radiotherapy (MRgRT)? We’re looking for standout content: creative media, inspiring clinical cases, and innovative approaches that highlight the real impact of MRgRT in transforming treatment. 💡 Submit your entry today! lnkd.in/e3cc6-2k
000
MR-Linac Consortium @mrlconsortium.bsky.social · 15/12/2025
Radiographer-led adaptive #MRgRT workflows are reshaping radiotherapy, streamlining processes, and improving patient experience. Hear Charlie Tran from GenesisCare Australia : lnkd.in/erTKBt6C #ProgressThroughCollaboration mrlconsortium.org
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
000
MR-Linac Consortium @mrlconsortium.bsky.social · 24/11/2025
000
MR-Linac Consortium @mrlconsortium.bsky.social · 17/11/2025
Celebrating Global Collaboration in MR-Linac Research! The MR-Linac Consortium continues to thrive as a truly international community, united by a shared mission to advance precision radiation therapy. Don’t miss this conversation with Dr. Qian Peng, Radiation Oncologist in China: lnkd.in/eve3usMq
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
000
MR-Linac Consortium @mrlconsortium.bsky.social · 12/11/2025
At the 20th Consortium meeting, it was inspiring to connect with so many members and see the progress being made in MRgRT. We're grateful to all who contributed their expertise and enthusiasm. Until next time!
011
MR-Linac Consortium @mrlconsortium.bsky.social · 07/11/2025
We are thrilled that Rad Chat joined us at the MR-Linac Consortium meeting! Rad Chat is a multi award winning podcast, education and social media platform focusing on radiotherapy and oncology. Curious to hear what Consortium attendees shared with them. Listen here: radchat.transistor.fm/episodes
010
MR-Linac Consortium @mrlconsortium.bsky.social · 07/11/2025
Today we awarded the best clinical, technical and young investigator abstracts. Congrats to this year's winners: Julia Peltenburg and Marlies Nowee, Xiangyu Zhang and Tariq Lalmahomed for their work in motion management, prostate cancer QoL and liver oligometastases treatment.
021
MR-Linac Consortium @mrlconsortium.bsky.social · 05/11/2025
The MR-Linac Consortium meeting kicked off today with 300+ members focused on sharing clinical data, research and the future of MRgRT. Huge thanks to our 2025 Organization Committee and Clinical Steering Committee Chair, Dr. Alison Tree, for driving MR-adaptive forward.
021
MR-Linac Consortium @mrlconsortium.bsky.social · 24/10/2025
📄 This MOMENTUM study highlights the safety and tolerability of MRI-guided SBRT for liver metastases, showing promising results in maintaining disease control with manageable side effects. Patients reported a stable quality of life throughout treatment. lnkd.in/eN8sEzmz #MOMENTUM #LiverCancer
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
000
MR-Linac Consortium @mrlconsortium.bsky.social · 21/10/2025
www.mrlconsortium.org #ProgressThroughCollaboration
000
MR-Linac Consortium @mrlconsortium.bsky.social · 08/10/2025
Research from UTSW explores how PSMA-PET imaging can guide adaptive SABR in high-risk prostate cancer—refining tumor boosts based on response, without adding treatment time. MR-Linac and CBCT systems can offer practical paths to personalized, biology-driven radiotherapy. lnkd.in/e4pHnZg2
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
020
MR-Linac Consortium @mrlconsortium.bsky.social · 03/10/2025
We’re thrilled to announce that the speaker lineup for the MR-Linac Consortium Meeting this November is confirmed! Last year’s meeting brought together brilliant minds, bold ideas, and transformative conversations in MR-guided radiotherapy and this year promises to be even more impactful.
000
MR-Linac Consortium @mrlconsortium.bsky.social · 22/09/2025
This study explores the feasibility and early outcomes of MR-guided stereotactic ablative radiotherapy (MRgSTAR) for patients with synchronous oligometastatic prostate cancer (OMPC). ✅ 100% 3-year overall survival ✅ 95.2% progression-free survival www.frontiersin.org/journals/onc...
frontiersin.org
Frontiers | Stereotactic total ablative radiotherapy with MR-LINAC for synchronous oligometastatic prostate cancer
ObjectivesTo prospectively investigate the feasibility, toxicity, and preliminary clinical outcomes of magnetic resonance (MR)-guided stereotactic total abla...
000
MR-Linac Consortium @mrlconsortium.bsky.social · 16/09/2025
000
MR-Linac Consortium @mrlconsortium.bsky.social · 11/09/2025
This retrospective analysis of five patients treated in the MOMENTUM study highlights that daily MR-adaptation reduces dose variability and OAR exposure compared to MR-guided plans alone for cervical cancer. #CervicalCancer #MOMENTUM medicaljournalssweden.se/actaoncologi...
medicaljournalssweden.se
Quantifying the dosimetric impact of online daily adaptation for MR-guided RT in cervical cancer | Acta Oncologica
000
MR-Linac Consortium @mrlconsortium.bsky.social · 19/08/2025
www.mrlconosrtium.org
000
MR-Linac Consortium @mrlconsortium.bsky.social · 14/08/2025
🚨A recent study leveraging MOMENTUM’s extensive dataset underlines that online adaptive MR-guided radiotherapy (MRgRT) shows promise for patients with non-metastatic pancreatic cancer. ✅ Maintained quality of life ✅ Significant symptom improvement at 6 months www.redjournal.org/article/S036...
redjournal.org
Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy
Online adaptive magnetic resonance guided radiation therapy (MRgRT) using a hybrid magnetic resonance imaging and linear accelerator enables stereotactic ablative radiation doses to pancreatic tumors....
010
MR-Linac Consortium @mrlconsortium.bsky.social · 06/08/2025
Advancing MR-Guided Radiotherapy in Esophageal Cancer A recent study from UMC Utrecht, explores the ATS-lite workflow—a simplified approach to online adaptive MRgRT which streamlines treatment delivery to a median of 23 minutes, while maintaining 90% target coverage.
phiro.science
A simplified online adaptive workflow for long-course magnetic resonance-guided radiotherapy in esophageal cancer
Since the publication of the landmark CROSS trial in 2012 [1], neoadjuvant chemoradiotherapy has become a cornerstone in the curative treatment of esophageal cancer in much of the western world. The r...
000
MR-Linac Consortium @mrlconsortium.bsky.social · 01/08/2025
Researchers in Nijmegen, Netherlands, have created an open-access online tool for early economic evaluation. This tool provides insights into the cost-effectiveness of MRIgRT. lnkd.in/e2sRxFRs Users can input their own data lnkd.in/erDkxXpF www.mrlconsortium.org hashtag#ProgressThroughCollaboration
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
010
MR-Linac Consortium @mrlconsortium.bsky.social · 17/07/2025
www.mrlconsortium.org #ProgressThroughCollaboration
000
Reposted by MR-Linac Consortium
Alison Tree @alison-tree.bsky.social · 27/06/2025
Excited to see the MARS trial highlighted here @cihangani.bsky.social @elekta.com @mrlconsortium.bsky.social @momentumstudy.bsky.social
MARS trial schema
082
MR-Linac Consortium @mrlconsortium.bsky.social · 07/07/2025
🗓️Is it time to retire the PTV concept? In this article, members of the MR-Linac Consortium in the Netherlands discuss advancements in online adaptive radiation therapy (RT) and its implications for planning target volume margins. 📊 www.redjournal.org/article/S036...
redjournal.org
Toward the End of Planning Target Volume Margins With Online Adaptive Radiation Therapy
Radiation therapy aims to cure patients by delivering the prescribed dose to the tumor with high precision. In the presence of positioning uncertainties, the question arises how to ensure that the act...
010
MR-Linac Consortium @mrlconsortium.bsky.social · 23/06/2025
This study from Brescia compared Elekta Unity with Accuray Radixact outcomes for oropharyngeal cancer treatment. It shows that daily ATS workflow for treatment is feasible and well-tolerated, with potential advantages compared to helical tomotherapy. www.ctro.science/article/S240...
ctro.science
Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapy
Oropharyngeal squamous cell carcinoma (OPSCC) is among the ten most common cancers worldwide and its incidence is growing due to increased exposure to major risk factors, including human papilloma vir...
010
MR-Linac Consortium @mrlconsortium.bsky.social · 18/06/2025
🔬 Transforming Cancer Care 💡 Explore how we're shaping the future of cancer care through: ✔️ Cutting-edge clinical research ✔️ A community dedicated to advancing patient outcomes ✔️ A global network of experts and institutions 🌐 Learn more at www.mrlconsortium.org #ProgressThroughCollaboration
000
MR-Linac Consortium @mrlconsortium.bsky.social · 10/06/2025
#ProgressThroughCollaboration www.mrlconsortium.org
000
MR-Linac Consortium @mrlconsortium.bsky.social · 04/06/2025
#ProgressThroughCollaboration www.mrlconsortium.org
000
MR-Linac Consortium @mrlconsortium.bsky.social · 30/05/2025
The HERMES trial from RMH London studied two MRI-guided adaptive prostate radiotherapy regimens. Both 5 and 2 fraction treatments are feasible with encouraging toxicity outcomes. www.redjournal.org/article/S036... @prostatecanceruk.bsky.social
redjournal.org
HERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapy
To demonstrate safety and feasibility of 2-fraction stereotactic body radiotherapy (SBRT) for prostate cancer.
000
MR-Linac Consortium @mrlconsortium.bsky.social · 29/05/2025
#ProgressThroughCollaboration www.mrlconsortium.org
000
MR-Linac Consortium @mrlconsortium.bsky.social · 20/05/2025
Sun Yat-sen University Cancer Centre report promising results for online hypo-fractionated adaptive MRgRT in treating brain metastases in non-small cell lung cancer. www.thelancet.com/journals/ecl... # progressthroughcollaboration @braintumourrsch.bsky.social @braintumourcharity.bsky.social
thelancet.com
Efficacy and safety of online adaptive magnetic resonance-guided fractionated stereotactic radiotherapy for brain metastases in non-small cell lung cancer (GASTO-1075): a single-arm, phase 2 trial
Online adaptive FSRT using a 1.5 T MR-Linac has demonstrated effectiveness and good tolerability for BMs in patients with NSCLC. However, the relatively small sample size and short follow-up may affec...
000
MR-Linac Consortium @mrlconsortium.bsky.social · 22/04/2025
This recent study from University of Iowa Health Care, describes the treatment strategies for 8 patients with central lung tumors using Comprehensive Motion Management on a 1.5T MR-Linac. www.frontiersin.org/journals/onc... @lungevity.bsky.social
frontiersin.org
Frontiers | Real-time tracking of lung tumors using a 1.5T Elekta Unity MR-Linac: first clinical experiences
000
MR-Linac Consortium @mrlconsortium.bsky.social · 15/04/2025
Some prostate patients experience urinary urgency during their radiation treatment. ​ That pressure can cause the prostate to move inferiorly, highlighted here in the video below courtesy of Dr Cem Onal, University of Başkent #ProgressThroughCollaboration
010
MR-Linac Consortium @mrlconsortium.bsky.social · 08/04/2025
Members of the Chinese MR Linac Consortium group recently published two interesting articles on treatment of large brain metastases and cardiac sarcoma using MRgRT. www.redjournal.org/article/S036... www.thegreenjournal.com/article/S016... #ProgressThroughCollaboration
redjournal.org
Safety and Efficacy of Unresectable Malignant Cardiac Tumors Treated with Concurrent Chemoradiation Therapy Using a 1.5T MR-Linac (GASTO-1078)
This trial aimed to investigate the safety and efficacy of treating malignant cardiac tumors with hypofractionated radiation therapy and concurrent chemotherapy (hypo-CCRT) using a 1.5T MR-Linac.
010
MR-Linac Consortium @mrlconsortium.bsky.social · 24/03/2025
The team at IOWA successfully commissioned the real-time target tracking and beam control system for the 1.5 T Elekta MR-Linac. aapm.onlinelibrary.wiley.com/doi/10.1002/... #Progressthroughcollaboration #mrlconsortium
aapm.onlinelibrary.wiley.com
<em>Journal of Applied Clinical Medical Physics</em> | AAPM Journal | Wiley Online Library
Purpose This work describes a single institution experience of commissioning a real-time target tracking and beam control system, known as comprehensive motion management, for a 1.5 T Elekta MR-Lina...
010
MR-Linac Consortium @mrlconsortium.bsky.social · 17/03/2025
See and manage small bowel position changes with online adaptive MR-guided workflows! www.mrlconsortium.org
010
MR-Linac Consortium @mrlconsortium.bsky.social · 10/03/2025
Don't miss out on our next webinar! Everything you need to know to get started on scripting in Monaco with guest speaker Alex Solodkin. www.mrlconsortium.org
010
MR-Linac Consortium @mrlconsortium.bsky.social · 04/03/2025
With this study, Pim Borman won the Young Investigator award at the Consortium Meeting. This work nicely demonstrated the MR-Linac’s capability to handle VMAT and MLC tracking at the same time. www.phiro.science/article/S240...
phiro.science
Demonstration of motion-compensated volumetric modulated arc radiotherapy on an MR-linac
Intensity-modulated radiotherapy (IMRT) in combination with magnetic resonance imaging (MRI)-guided gated delivery represents the latest development in the treatment of abdominothoracic tumours on MR-...
010
MR-Linac Consortium @mrlconsortium.bsky.social · 25/02/2025
Dr. Alborz Jooya, a Radiation Oncologist at Alberta Health Services in Calgary, recently presented groundbreaking patient-reported quality of life findings at the MRL Consortium in Singapore, November 2024. #Healthcare #Oncology #PatientCare #QualityOfLife #MedicalResearch
010
MR-Linac Consortium @mrlconsortium.bsky.social · 12/02/2025
An international survey of 23 sites shows T2W MRI is preferred for urethra contouring to reduce urinary toxicity in prostate cancer patients undergoing EBRT. doi.org/10.1016/j.ct... @prostatecanceruk.bsky.social @prostatecancerguy.bsky.social
doi.org
Redirecting
000
MR-Linac Consortium @mrlconsortium.bsky.social · 05/02/2025
Don't miss out on our first webinar of 2025! Open to all MR-Linac Consortium members. Member Portal Access: www.mrlconsorium.org
010
MR-Linac Consortium @mrlconsortium.bsky.social · 29/01/2025
This article, utilizing data from MOMENTUM, demonstrates that MR-guided SBRT for pancreatic oligometastases from RCC is a promising, safe, and effective treatment. It may delay systemic therapy, providing high local control and low toxicity. doi.org/10.1016/j.ph... @kidneycancer.bsky.social
doi.org
Redirecting
020
MR-Linac Consortium @mrlconsortium.bsky.social · 23/01/2025
🔍 The Radiation Therapist (RTT) Brainstorm Group met during the annual MRL Consortium meeting in Singapore, Nov 2024. One of the topics of discussion was future opportunities for RTT role expansion. The word cloud shows key areas highlighted for consideration. 🔍 www.mrlconsortium.org
020
MR-Linac Consortium @mrlconsortium.bsky.social · 14/01/2025
🌟New Focus Article Alert 🌟Elekta’s latest Focus article showcases the outstanding contributions of the MRL Consortium members and provides an update on the recent meeting held in Singapore. Read article here: www.elekta.com/focus/mr-lin... #Elekta #MRLConsortium #HealthcareInnovation #MRgRT
elekta.com
19th MR-Linac Consortium meeting expands MRgRT horizons | Focus | Elekta
Enthusiasm for MRgRT continues to sweep the globe, as new uses arise clinical evidence pours in. Read about some of the key moments from the 19th Consortium meeting.
021
MR-Linac Consortium @mrlconsortium.bsky.social · 13/01/2025
With this study, Maximilian Konrad won the Technical Abstract award at the Consortium Meeting. He investigated the feasibility and time gain of implementing a home-made online AI-based contouring solution on Unity. www.phiro.science/article/S240... @prostatecanceruk.bsky.social
phiro.science
Feasibility and time gain of implementing artificial intelligence-based delineation tools in daily magnetic resonance image-guided adaptive prostate cancer radiotherapy
The integration of magnetic resonance imaging (MRI) with a radiotherapy linear accelerator (Linac) into an MRI-Linac offers the combination of the diagnostic image quality of MRI images with precise r...
020